CA3150865A1 - Capteur non invasif permettant de determiner un battement cardiaque et/ou un rythme cardiaque dans un segment d'un circuit sanguin extracorporel - Google Patents
Capteur non invasif permettant de determiner un battement cardiaque et/ou un rythme cardiaque dans un segment d'un circuit sanguin extracorporel Download PDFInfo
- Publication number
- CA3150865A1 CA3150865A1 CA3150865A CA3150865A CA3150865A1 CA 3150865 A1 CA3150865 A1 CA 3150865A1 CA 3150865 A CA3150865 A CA 3150865A CA 3150865 A CA3150865 A CA 3150865A CA 3150865 A1 CA3150865 A1 CA 3150865A1
- Authority
- CA
- Canada
- Prior art keywords
- signal
- frequency
- peak
- output signal
- segment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008280 blood Substances 0.000 title claims abstract description 205
- 210000004369 blood Anatomy 0.000 title claims abstract description 205
- 230000003287 optical effect Effects 0.000 claims abstract description 145
- 238000011282 treatment Methods 0.000 claims abstract description 65
- 230000001121 heart beat frequency Effects 0.000 claims abstract description 37
- 238000001228 spectrum Methods 0.000 claims description 188
- 230000005855 radiation Effects 0.000 claims description 105
- 230000000875 corresponding effect Effects 0.000 claims description 101
- 239000012530 fluid Substances 0.000 claims description 88
- 238000012545 processing Methods 0.000 claims description 77
- 238000000034 method Methods 0.000 claims description 65
- 238000001514 detection method Methods 0.000 claims description 33
- 238000004422 calculation algorithm Methods 0.000 claims description 27
- 230000009466 transformation Effects 0.000 claims description 24
- 238000001914 filtration Methods 0.000 claims description 23
- 230000008569 process Effects 0.000 claims description 21
- 239000000835 fiber Substances 0.000 claims description 19
- 230000004087 circulation Effects 0.000 claims description 16
- 238000010168 coupling process Methods 0.000 claims description 11
- 238000005859 coupling reaction Methods 0.000 claims description 11
- 238000005070 sampling Methods 0.000 claims description 11
- 230000008878 coupling Effects 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 238000010009 beating Methods 0.000 claims description 9
- 239000000385 dialysis solution Substances 0.000 claims description 9
- 238000004458 analytical method Methods 0.000 claims description 8
- 238000004364 calculation method Methods 0.000 claims description 7
- 230000000747 cardiac effect Effects 0.000 claims description 7
- 125000004122 cyclic group Chemical group 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 6
- 230000002596 correlated effect Effects 0.000 claims description 5
- 238000011161 development Methods 0.000 claims description 5
- 230000005670 electromagnetic radiation Effects 0.000 claims description 5
- 238000011068 loading method Methods 0.000 claims description 5
- 210000000748 cardiovascular system Anatomy 0.000 claims description 4
- 238000004891 communication Methods 0.000 claims description 4
- 230000002792 vascular Effects 0.000 claims description 4
- 230000001427 coherent effect Effects 0.000 claims description 3
- 239000002131 composite material Substances 0.000 claims description 2
- 230000001276 controlling effect Effects 0.000 claims description 2
- 238000010790 dilution Methods 0.000 description 23
- 239000012895 dilution Substances 0.000 description 23
- 238000010586 diagram Methods 0.000 description 21
- 238000001802 infusion Methods 0.000 description 19
- 239000003978 infusion fluid Substances 0.000 description 18
- 230000000670 limiting effect Effects 0.000 description 13
- 230000002572 peristaltic effect Effects 0.000 description 12
- 238000000108 ultra-filtration Methods 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 230000006870 function Effects 0.000 description 9
- 229920003023 plastic Polymers 0.000 description 9
- 239000003792 electrolyte Substances 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 238000012935 Averaging Methods 0.000 description 7
- 230000003321 amplification Effects 0.000 description 7
- 238000000502 dialysis Methods 0.000 description 7
- 238000003199 nucleic acid amplification method Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 230000005540 biological transmission Effects 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 230000029058 respiratory gaseous exchange Effects 0.000 description 6
- 230000000284 resting effect Effects 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 238000002615 hemofiltration Methods 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000013500 data storage Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 230000007717 exclusion Effects 0.000 description 3
- 238000001631 haemodialysis Methods 0.000 description 3
- 230000000322 hemodialysis Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000005534 hematocrit Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000010183 spectrum analysis Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000009304 Acute Kidney Injury Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010021137 Hypovolaemia Diseases 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 208000033626 Renal failure acute Diseases 0.000 description 1
- 241000510009 Varanus griseus Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000011040 acute kidney failure Diseases 0.000 description 1
- 208000012998 acute renal failure Diseases 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000002616 plasmapheresis Methods 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011012 sanitization Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Abstract
L'invention concerne un capteur de battement cardiaque non invasif permettant de déterminer un rythme cardiaque dans un conduit d'un appareil de traitement sanguin extracorporel, comprenant une source permettant de diriger un signal optique vers le sang s'écoulant dans le segment ; un détecteur permettant de recevoir un signal d'information optique comprenant le signal émis par ladite source après passage du sang, et d'émettre un signal de sortie respectif ; un dispositif de commande recevant le signal de sortie respectif et récupérant une fréquence de battement cardiaque et une valeur de rythme cardiaque, en fonction du signal de sortie, le signal d'information étant modifié par une perturbation d'écoulement du sang partiellement généré par les impulsions d'écoulement provenant du c?ur.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19198444 | 2019-09-19 | ||
| EP19198444.2 | 2019-09-19 | ||
| PCT/EP2020/076200 WO2021053201A1 (fr) | 2019-09-19 | 2020-09-18 | Capteur non invasif permettant de déterminer un battement cardiaque et/ou un rythme cardiaque dans un segment d'un circuit sanguin extracorporel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3150865A1 true CA3150865A1 (fr) | 2021-03-25 |
Family
ID=67998193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3150865A Pending CA3150865A1 (fr) | 2019-09-19 | 2020-09-18 | Capteur non invasif permettant de determiner un battement cardiaque et/ou un rythme cardiaque dans un segment d'un circuit sanguin extracorporel |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA3150865A1 (fr) |
-
2020
- 2020-09-18 CA CA3150865A patent/CA3150865A1/fr active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4895952B2 (ja) | 脈遷移時間を決定するための処理及び装置及びそのような装置を有する体外血液療法設備 | |
| JP4711454B2 (ja) | 空気の存在について流動液体を監視する監視方法及び装置 | |
| JP4868772B2 (ja) | 血液浄化装置 | |
| US6178342B1 (en) | Surface perfusion pressure monitoring system | |
| ES2230647T3 (es) | Dispositivo para procedimiento y la vigilancia continua de un tratamiento extracorporal de la sangre. | |
| AU2008354310B2 (en) | An apparatus and a method for monitoring a vascular access | |
| US6167765B1 (en) | System and method for determining the flow rate of blood in a vessel using doppler frequency signals | |
| US6878272B2 (en) | Dialyzing apparatus | |
| KR102220982B1 (ko) | 체외 혈액 치료 중 재순환을 검출하는 장치 및 방법 | |
| WO2016117674A1 (fr) | Dispositif de purification du sang | |
| JP5536192B2 (ja) | 体外血液処理装置用の血液中の血液成分を測定するための装置及び方法 | |
| CN112203578A (zh) | 用于确定体外血液回路中循环的血液的至少一个参数的传感器和设备 | |
| CN101516418B (zh) | 用于检测流体系统特别是血液处理设备的体外血液回路中的空气的方法和设备 | |
| JP2017509394A (ja) | 自己校正する血液チャンバ | |
| KR20020093105A (ko) | 투석기의 회로에 있는 혈액의 헤모글로빈 농도를 측정하는방법과, 이 방법을 실시하기 위한 측정 장치 및 회로 | |
| JP4573231B2 (ja) | 血液浄化装置 | |
| EP4031207B1 (fr) | Capteur non-invasif pour determiner le battement du coeur et/ou le rythme cardiaque dans un segment d'un circuit du sang extracorporel | |
| CA3150865A1 (fr) | Capteur non invasif permettant de determiner un battement cardiaque et/ou un rythme cardiaque dans un segment d'un circuit sanguin extracorporel | |
| WO2007105805A1 (fr) | Sonde de mesure des caracteristiques du sang, organe artificiel du systeme cardiovasculaire et poumon artificiel | |
| US11744930B2 (en) | Intradialytic monitoring of hemodynamic status based on detection of oxygen signature phase shift | |
| IT201900016787A1 (it) | Non-invasive sensor for determining a heartbeat and/or heart rate in an extracorporeal segment of a conduit for an extracorporeal blood circuit. | |
| EP1273315A1 (fr) | Dispositif de contrôle de l'élimination d'eau dans un appareil de dialyse | |
| US20240075247A1 (en) | Dual lumen catheter | |
| CN220608776U (zh) | 一种无创监测ecmo膜肺效能的装置 | |
| JP2024054703A (ja) | 血液浄化装置 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220907 |
|
| EEER | Examination request |
Effective date: 20220907 |
|
| EEER | Examination request |
Effective date: 20220907 |
|
| EEER | Examination request |
Effective date: 20220907 |
|
| EEER | Examination request |
Effective date: 20220907 |